Novo Nordisk A/S
(OMX Nordic Exchange Copenhagen A/S : NONOF)

( )
NONOF After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 3.32%133.080.7%$2112.60m
PFEPfizer Inc. 3.53%32.870.9%$1387.47m
MRKMerck & Co., Inc. 4.12%76.840.7%$1300.89m
ABBVAbbVie, Inc. 2.37%75.162.3%$1236.30m
BMYBristol-Myers Squibb Co. 1.47%55.171.0%$1077.97m
LLYEli Lilly & Co. 4.20%142.151.1%$915.90m
NVSNovartis AG 3.25%83.560.2%$310.08m
AZNAstraZeneca Plc -0.11%43.731.2%$290.86m
GSKGlaxoSmithKline Plc 1.34%37.720.2%$255.80m
FTSVForty Seven, Inc. -0.01%95.430.0%$186.11m
NVONovo Nordisk A/S -0.74%59.310.1%$171.16m
SNYSanofi 1.40%43.510.2%$159.05m
BHCBausch Health Cos., Inc. -1.31%13.570.0%$88.68m
RARXRa Pharmaceuticals, Inc. -0.03%48.000.8%$82.28m
RGENRepligen Corp. 2.78%96.957.1%$73.08m

Company Profile

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.